10:11 AM EDT, 10/28/2025 (MT Newswires) -- (Update with Kenvue's ( KVUE ) and Johnson & Johnson's ( JNJ ) responses to requests for comment from MT Newswires in the fourth and fifth paragraphs, respectively.)

Texas Attorney General Ken Paxton said Tuesday he has sued Johnson & Johnson ( JNJ ) and Kenvue ( KVUE ) for allegedly using deception in marketing Tylenol to pregnant women "despite knowing that early exposure to acetaminophen, Tylenol's only active ingredient, leads to significantly increased risk of autism and other disorders."

The American College of Obstetricians & Gynecologists on Sept. 22 refuted claims from the Trump administration linking Tylenol use in pregnancy to autism.

"Suggestions that acetaminophen use in pregnancy causes autism are not only highly concerning to clinicians but also irresponsible when considering the harmful and confusing message they send to pregnant patients, including those who may need to rely on this beneficial medicine during pregnancy," ACOG President Steven Fleischman said.

In an emailed statement to MT Newswires, Kenvue ( KVUE ) said, "Acetaminophen is the safest pain reliever option for pregnant women as needed throughout their entire pregnancy. We will defend ourselves against these baseless claims and respond per the legal process. We stand firmly with the global medical community that acknowledges the safety of acetaminophen and believe we will continue to be successful in litigation as these claims lack legal merit and scientific support."

"Johnson & Johnson ( JNJ ) divested its consumer health business years ago, and all rights and liabilities associated with the sale of its over-the-counter products, including Tylenol (acetaminophen), are owned by Kenvue ( KVUE )," a Johnson & Johnson ( JNJ ) spokesperson told MT Newswires via email.

Price: 14.85, Change: -0.23, Percent Change: -1.56